Simon G Gregory
Biographic Data
| ID | 9508533 |
|---|---|
| NAME | Simon G Gregory |
| GIVEN NAMES | Simon G |
| FAMILY NAME | Gregory |
| SIGNATURE | GREGORY S G |
| AFFILIATIONS | Department of Neurology Duke University School of Medicine Durham NC USA |
| ORCID | 0000-0002-7805-1743 |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2001 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Evaluating placebo responses to intranasal oxytocin in autism: Findings from the placebo lead‐in phase of a randomised controlled trial
BACKGROUND: The placebo effect is established in clinical trials, but for paediatric research, questions remain about how to best manage its influence. Within the autism field, data on these issues is sparse. This is particularly important in the oxytocin field where placebo responses are thought to play an important role. This study reports on data from the single-blind, placebo lead-in phase of a randomised controlled trial (RCT) to investigate…
Initial sequencing and analysis of the human genome
The human genome holds an extraordinary trove of information about human development, physiology, medicine and evolution. Here we report the results of an international collaboration to produce and make freely available a draft sequence of the human genome. We also present an initial analysis of the data, describing some of the insights that can be gleaned from the sequence.
No prominent works on this page.
Initial sequencing and analysis of the human genome
The human genome holds an extraordinary trove of information about human development, physiology, medicine and evolution. Here we report the results of an international collaboration to produce and make freely available a draft sequence of the human genome. We also present an initial analysis of the data, describing some of the insights that can be gleaned from the sequence.
Evaluating placebo responses to intranasal oxytocin in autism: Findings from the placebo lead‐in phase of a randomised controlled trial
BACKGROUND: The placebo effect is established in clinical trials, but for paediatric research, questions remain about how to best manage its influence. Within the autism field, data on these issues is sparse. This is particularly important in the oxytocin field where placebo responses are thought to play an important role. This study reports on data from the single-blind, placebo lead-in phase of a randomised controlled trial (RCT) to investigate…
Autism Spectrum Disorder Research (1 works) · Biology (1 works) · Clinical trial (1 works) · Computational biology (1 works) · Computer Science (1 works) · Data science (1 works) · DNA sequencing (1 works) · Evolutionary biology (1 works) · Gene (1 works) · Genetics (1 works)